Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other solid neoplasm 1Gastrointestinal 1

Conditions

Colonic Neoplasms 1

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 213Irinotecan 146Leucovorin 140Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Bevacizumab 99Drug Therapy 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Drug Combinations × Gastrointestinal × Clear all
NCT02882269 2016-08-30

Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase 2/3 Unknown
400 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡